Ondine Biomedical Inc. NPV (CDI)

(OBI)
Sector: Pharmaceuticals & Biotechnology
8.75p
0.00p 0.00
Last updated: 16:57:08

Share information

Name Ondine Biomedical Inc. NPV (CDI)
Epic OBI
Isin CA68234M2058
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 8.75p Net gearing n/a
Market capitalisation £24.35 Debt ratio n/a
Shares in issue 277.29 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -152.96
Dividend cover n/a EPS growth n/a
Earning per share -10 52-week high / low 5.13p / 10.75p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Ondine Biomedical Inc. NPV (CDI)
Address 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Telephone +1 604 669 0555
Website https://ondinebio.com/

Directors

Director Position
Ms Carolyn Cross CEO
Mr Jean Charest Chairman
Mr Michael Farrar Non-Executive Director
Mr Craig Tooman Non-Executive Director
Mr Nicolas Loebel Chief Technology Officer
Ms Jean Duvall Senior Independent Non-Executive Director
Dr Simon Sinclair Independent Non-Executive Director
Dr Junaid Bajwa Independent Non-Executive Director
Mr Kwong Choo Interim CFO

Company financials

Assets CAD (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill n/a n/a 0.17
Investments and other non-current assets n/a n/a n/a
Total non-current assets 1.44 0.64 0.89
Inventory / work in progress 1.29 1.06 0.4
Trade and other receivables 0.56 2.08 0.72
Cash and equivalents 13.12 30.36 0.63
Other current assets and asset held for resale 0.15 n/a n/a
Total of all assets 16.57 34.14 2.63
Liabilities CAD (m) 2022 2021 2020
Short term liabilities 3.91 3.92 35.79
Long term liabilities 1.02 0.56 0.68
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 4.92 4.48 36.46
Net assets CAD (m) 2022 2021 2020
Net assets 11.64 29.66 -33.83
Equity CAD (m) 2022 2021 2020
Share capital 235.04 235.04 119.53
Minority interests n/a n/a -0.01
Retained earnings -251.92 -232.54 -182.14
Share premium account 10.53 10.53 10.38
Total equity 11.64 29.66 -33.83
Income CAD (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -18.76 -17.52 -15.87
Pre-tax profit -19.37 -50.09 -16.27